Showing results (41-50 of 126) with videos related to
Sort By:
Pageof 13
Oncotarget|May 19, 2018
An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapyBruno Christian Köhler, Benjamin Goeppert, Nina Waldburger, et al.BMC Cancer|October 4, 2013
High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinomaAlbrecht Stenzinger, Volker Endris, Frederick Klauschen, et al.Frontiers in Immunology|October 11, 2023
Regulatory T-cell deficiency leads to features of autoimmune liver disease overlap syndrome in scurfy miceKaan Yilmaz, Stefanie Haeberle, Yong Ook Kim, et al.Cell Communication and Signaling : CCS|December 1, 2019
Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancerElisabeth Drucker, Kerstin Holzer, Stefan Pusch, et al.Proteomics. Clinical Applications|February 1, 2020
Microproteomics and Immunohistochemistry Reveal Differences in Aldo-Keto Reductase Family 1 Member C3 in Tissue Specimens of Ulcerative Colitis and Crohn's DiseaseKarim Arafah, Mark Kriegsmann, Marcus Renner, et al.Hepatology (Baltimore, Md.)|May 9, 2015
The BH3-only protein BID impairs the p38-mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in miceJohanna Orlik, Sven Schüngel, Laura Elisa Buitrago-Molina, et al.Journal of Neuroscience Research|March 6, 2007
Expression pattern of the water channel aquaporin-4 in human gliomas is associated with blood-brain barrier disturbance but not with patient survivalArne Warth, Perikles Simon, David Capper, et al.Brain Pathology (Zurich, Switzerland)|May 21, 2008
EGR-1 is regulated by N-methyl-D-aspartate-receptor stimulation and associated with patient survival in human high grade astrocytomasMichel Mittelbronn, Patrick Harter, Arne Warth, et al.International Journal of Molecular Sciences|February 13, 2020
Knockdown of Atg7 Induces Nuclear-LC3 Dependent Apoptosis and Augments Chemotherapy in Colorectal Cancer CellsAnna-Lena Scherr, Adam Jassowicz, Anna Pató, et al.Ejhaem|July 18, 2022
Ruxolitinib is effective in the treatment of a patient with refractory T-ALLSonia Jaramillo, Hannah Hennemann, Peter Horak, et al.Pageof 13